Skip to content

Effect of Single Intravenous Injection of Lidocaine on Intraoperative Tourniquet Pain and Postoperative Recovery in Daytime Knee Arthroscopy

Effect of Single Intravenous Injection of Lidocaine on Intraoperative Tourniquet Pain and Postoperative Recovery in Daytime Knee Arthroscopy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055551
Enrollment
Unknown
Registered
2022-01-12
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative tourniquet pain in knee arthroscopic surgery

Interventions

Lidocaine group:10 minutes before tourniquet inflation, lidocaine 1.5 mg / kg was injected intravenously and diluted with 10 ml normal saline at a rate of 1 ml / s.
Normal saline group:10ml normal saline was injected intravenously at a rate of 1ml / s 10 minutes before tourniquet inflation.

Sponsors

Department of Anesthesiology, the First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing knee arthroscopy with tourniquet under daytime selective general anesthesia, ASA I-II; 2. Aged 18 to 65 years; 3. BMI 18-30 kg/m2; 4. Normal communication; 5. Voluntary subjects and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. History of hypertension, peripheral vascular disease, history of diabetes and history of cerebral infarction; 2. History of deep venous thrombosis; 3. Heart, liver or kidney disease; 4. History of allergic reactions or seizures to amide local anesthetics; 5. History of chronic analgesics, opioid addicts and non steroidal anti-inflammatory drugs; 6. Mental history: such as schizophrenia, depression, dementia; 7. The quality of postoperative recovery scale (QoR-15) or visual analogue scale (VAS) were not understood.

Design outcomes

Primary

MeasureTime frame
Incidence of intraoperative tourniquet pain or tourniquet hypertension;

Secondary

MeasureTime frame
Hemodynamic changes;Changes in interleukin-6 (IL-6) concentration in venous blood samples;Changes in tumor necrosis factor a(TNF-a)concentration in venous blood samples;Use of antihypertensive drugs or heart rate lowering drugs;15-item Quality of Recovery,QoR-15;Pain digital analog score(VAS));hospital stay;Postoperative nausea and vomiting;Use of remedial painkillers and remedial antiemetics;Other complications such as dizziness, hypotension or hypertension;

Countries

China

Contacts

Public ContactLu Yao

Department of Anesthesiology, the First Affiliated Hospital of Anhui Medical University

luyao-mz@163.com+86 18956564060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026